Abstract
Alkaloid lappaconitine (I) and its derivatives – N(20)-deethyllappaconitine (II) and 5-bromolappaconitine (III) in the base form and as salts - hydrochloride (I • HCl), hydrobromide (preparation allapinine) (I • HBr), hydrobromide (II • HBr), hydrobromide (III • HBr), succinate (I • Suc) were taken for research of pharmacology activity. Moreover, pharmacology activity was investigated for a clathrates of lappaconitine – the bases, hydrochloride and hydrobromide with glycyrrhizic acid (IV) (I-IV; I • HCl-IV; I • HBr-IV). It is shown that, neither the base nor the salts, with the exception for hydrobromide, possess antiarrhythmic action on any of the models. Among glycyrrhizic acid clathrates, only the clathrate with hydrobromide of lappaconitine (I • HBr-IV) has a high activity on the two models of arrhythmia.
Keywords: Antiarrhythmic agent, Lappaconitine compounds, Clathrate
Letters in Drug Design & Discovery
Title: Solification with Hydrobromic Acid as a Factor Defining the Antiarrhythmic Effect of Lappaconitine Derivatives
Volume: 6 Issue: 7
Author(s): T. G. Tolstikova, A. O. Bryzgalov, I. V. Sorokina, S. A. Osadchii, E. E. Shults, M. P. Dolgikh and M. V. Khvostov
Affiliation:
Keywords: Antiarrhythmic agent, Lappaconitine compounds, Clathrate
Abstract: Alkaloid lappaconitine (I) and its derivatives – N(20)-deethyllappaconitine (II) and 5-bromolappaconitine (III) in the base form and as salts - hydrochloride (I • HCl), hydrobromide (preparation allapinine) (I • HBr), hydrobromide (II • HBr), hydrobromide (III • HBr), succinate (I • Suc) were taken for research of pharmacology activity. Moreover, pharmacology activity was investigated for a clathrates of lappaconitine – the bases, hydrochloride and hydrobromide with glycyrrhizic acid (IV) (I-IV; I • HCl-IV; I • HBr-IV). It is shown that, neither the base nor the salts, with the exception for hydrobromide, possess antiarrhythmic action on any of the models. Among glycyrrhizic acid clathrates, only the clathrate with hydrobromide of lappaconitine (I • HBr-IV) has a high activity on the two models of arrhythmia.
Export Options
About this article
Cite this article as:
Tolstikova G. T., Bryzgalov O. A., Sorokina V. I., Osadchii A. S., Shults E. E., Dolgikh P. M. and Khvostov V. M., Solification with Hydrobromic Acid as a Factor Defining the Antiarrhythmic Effect of Lappaconitine Derivatives, Letters in Drug Design & Discovery 2009; 6 (7) . https://dx.doi.org/10.2174/157018009789108312
DOI https://dx.doi.org/10.2174/157018009789108312 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Keap1 as Target of Genistein on Nrf2 Signaling Pathway Antagonizing Aβ
induced Oxidative Damage of Cerebrovascular Endothelial Cells
Current Neurovascular Research Hepatoprotective Potential of Phytoconstituents and Vitamins against Antitubercular Drugs Induced Hepatotoxicity in Albino Rats
Current Drug Therapy Descriptive Analysis of Mortality Predictors in H1n1 Influenza in South Indian Patients
Infectious Disorders - Drug Targets Progress in the Mechanism and Clinical Application of Cilostazol
Current Topics in Medicinal Chemistry Therapeutic Applications of Prostaglandins and Thromboxane A2 Inhibitors in Abdominal Aortic Aneurysms
Current Drug Targets Cerebrolysin, a Mixture of Neurotrophic Factors Induces Marked Neuroprotection in Spinal Cord Injury Following Intoxication of Engineered Nanoparticles from Metals
CNS & Neurological Disorders - Drug Targets Beneficial Effects of Corn Silk on Metabolic Syndrome
Current Pharmaceutical Design A Simplified Framework for the Detection of Intracranial Hemorrhage in CT Brain Images Using Deep Learning
Current Medical Imaging Cholesterol Absorption Blockade with Ezetimibe
Current Drug Targets - Cardiovascular & Hematological Disorders Sigma-1 Receptors and Selective Serotonin Reuptake Inhibitors: Clinical Implications of their Relationship
Central Nervous System Agents in Medicinal Chemistry Determination of Manidipine in Human Plasma by UPLC–MS/MS and its Application to a Bioequivalence Study
Current Pharmaceutical Analysis Update on Pharmacologic Approaches to Prevent Thromboembolism in Atrial Fibrillation: Are Thrombin and Factor Xa Inhibitors the Ultimate Answer?
Current Vascular Pharmacology Preface
Current Traditional Medicine Advances in the Management of Heart Failure with Reduced Ejection Fraction; The Role of SGLT2is, ARNI, Myotropes, Vericiguat, and Anti-inflammatory Agents: A Mini-review
Current Pharmaceutical Design Editorial [Hot Topic: Adenosine-Based Modulation of Brain Activity (Guest Editor: DETLEV BOISON)]
Current Neuropharmacology Meet Our Editor
Cardiovascular & Hematological Agents in Medicinal Chemistry A Journey through Genetic Architecture and Predisposition of Coronary Artery Disease
Current Genomics Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases
Current Pharmaceutical Design Inflammatory Process as a Determinant Factor for the Degeneration of Substantia Nigra Dopaminergic Neurons: Possible Relevance to the Etiology of Parkinsons Disease
Current Medicinal Chemistry - Central Nervous System Agents Editorial [Hot Topic: The Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
Current Pharmaceutical Design